Clinical Trials
41 trialsCOAST
Medical University of South Carolina
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
University of Arkansas
REPAIR
Institut Cancerologie de l'Ouest
PragMet
University of Colorado, Denver
Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer
University of California, Davis
NivoMet
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
PRIME
Canadian Urologic Oncology Group
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer
Cairo University
PREMIUM
AHS Cancer Control Alberta
MAST
University Health Network, Toronto
TROJAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
Swiss Cancer Institute
STAMPEDE
Medical Research Council
PRIMA
Rutgers, The State University of New Jersey
Metformin Prostate Cancer Adjuvant Trial
NYU Langone Health
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Swiss Cancer Institute
BIMET-1
Fox Chase Cancer Center
The Effect of Metformin in Patients With Newly Diagnosed mHSPC
Sun Yat-sen University
The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University
LIGAND
University Health Network, Toronto
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Swiss Cancer Institute
MetAb-Pro
Kantonsspital Graubünden
Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients
Medical University of South Carolina
TAXOMET
Centre Antoine Lacassagne
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer
The University of Texas Health Science Center at San Antonio
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
National Cancer Institute (NCI)
M-RePoRT
Icahn School of Medicine at Mount Sinai
Metformin in Castration-Resistant Prostate Cancer
Massachusetts General Hospital
Mansmed
Mansoura University
Metformin and Simvastatin Use in Bladder Cancer
London Health Sciences Centre
METAL
Guy's and St Thomas' NHS Foundation Trust
Study of Metformin With Simvastatin for Men With Prostate Carcinoma
Baylor College of Medicine
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
University of Cape Coast
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
National Cancer Institute (NCI)
Prostate Cancer Active Surveillance Metformin Trial
University Health Network, Toronto
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer
New Mexico Cancer Research Alliance
ANIMATE
University Health Network, Toronto